[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Matthew Herper [@matthewherper](/creator/twitter/matthewherper) on x 109.5K followers Created: 2025-06-23 18:40:11 UTC Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing, @elainychen writes  XXXXX engagements  **Related Topics** [rates](/topic/rates) [Post Link](https://x.com/matthewherper/status/1937219147416379577)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Matthew Herper @matthewherper on x 109.5K followers
Created: 2025-06-23 18:40:11 UTC
Amgen’s obesity drug led to high discontinuation rates in mid-stage trial, as company plans to adjust dosing, @elainychen writes
XXXXX engagements
Related Topics rates
/post/tweet::1937219147416379577